Citadel Advisors’s HOOKIPA Pharma HOOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,500
Closed -$2.7K 13590
2025
Q1
$2.7K Sell
2,500
-300
-11% -$494 ﹤0.01% 14016
2024
Q4
$5.63K Buy
2,800
+1,520
+119% +$4.7K ﹤0.01% 13848
2024
Q3
$5.5K Sell
1,280
-830
-39% -$4.38K ﹤0.01% 13481
2024
Q2
$12.5K Sell
2,110
-2,250
-52% -$17.8K ﹤0.01% 12982
2024
Q1
$31K Buy
+4,360
New +$31K ﹤0.01% 12669
2023
Q4
Sell
-240
Closed -$1.48K 14701
2023
Q3
$1.48K Sell
240
-210
-47% -$1.54K ﹤0.01% 13860
2023
Q2
$3.96K Buy
450
+400
+800% +$4.44K ﹤0.01% 13641
2023
Q1
$368 Hold
50
﹤0.01% 14511
2022
Q4
$405 Buy
+50
New +$542 ﹤0.01% 14667
2022
Q3
Sell
-1,510
Closed -$25K 13031
2022
Q2
$25K Sell
1,510
-4,330
-74% -$71.7K ﹤0.01% 12307
2022
Q1
$133K Buy
5,840
+3,390
+138% +$60.8K ﹤0.01% 11981
2021
Q4
$57K Sell
2,450
-2,290
-48% -$92K ﹤0.01% 13177
2021
Q3
$279K Sell
4,740
-8,600
-64% -$624K ﹤0.01% 11206
2021
Q2
$1.22M Buy
13,340
+2,670
+25% +$356K ﹤0.01% 7818
2021
Q1
$1.44M Buy
10,670
+2,910
+38% +$351K ﹤0.01% 7217
2020
Q4
$861K Buy
+7,760
New +$838K ﹤0.01% 7109

Other funds holding HOOK

Citadel Advisors's HOOK Position: Q2 2025 in Review

Citadel Advisors sold out of HOOKIPA Pharma (HOOK) in Q2 2025, closing a stake of 10,366 shares — an estimated $11.2K sold.

Citadel Advisors first reported a position in HOOK in Q1 2021 and held it in 12 quarters. The position peaked at $587K in Q2 2021. 27 funds tracked by Wall St. Rank hold HOOK as of Q2 2025.

  • Citadel Advisors reported no remaining HOOKIPA Pharma position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 10,366 HOOKIPA Pharma shares in Q2 2025, an estimated $11.2K.
  • Citadel Advisors first reported a position in HOOKIPA Pharma in Q1 2021 and held it in 12 quarters.
  • Citadel Advisors's HOOKIPA Pharma position peaked at $587K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.